Yingjun Yan

Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer

Christine M. Lovly, Nerina T. McDonald, Heidi Chen et al. · Nature Medicine · 2014 · 265 citations · Full text

Medicine, Cancer Biology, Co-targeting Igf-1r +7

SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer

Eiki Ichihara, David Westover, Catherine B. Meador et al. · Cancer Research · 2017 · 141 citations

Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse

Karinna Almodovar, Wade T. Iams, Catherine B. Meador et al. · Journal of Thoracic Oncology · 2017 · 135 citations · Full text

Oncology, Tumor Heterogeneity, Treatment Efficacy +8

<i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer

Kartik Konduri, Jean‐Nicolas Gallant, Young Kwang Chae et al. · Cancer Discovery · 2016 · 124 citations · Full text

Improved Identification of Yeast Species Directly from Positive Blood Culture Media by Combining Sepsityper Specimen Processing and Microflex Analysis with the Matrix-Assisted Laser Desorption Ionization Biotyper System

Yingjun Yan, Ying He, Thomas Maier et al. · Journal of Clinical Microbiology · 2011 · 111 citations · Full text